Global Innovative Platforms (GIPL) Net Cash Flow Growth (5y) (2026)
Analysis
Global Innovative Platforms (GIPL) Net Cash Flow Growth (5y) (2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.53 Bn | 40.34 Bn | 779.09 Mn |
| 2 | Zoetis | 30.65 Bn | 28.97 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.81 Bn | 11.28 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.51 Bn | 1.42 Bn | 134.40 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |